High Technical Success Rate of Endoscopic Balloon Dilatation Reduces Surgical Requirement for Patients With Stricturing Crohn’s Disease
Emily Lim(University of Massachusetts Chan Medical School), Jakob Begun(Translational Research Institute), Rupert W. Leong(The University of Sydney), Watson Ng(Liverpool Hospital), Bonita Gu(Royal Prince Alfred Hospital), Mahmoud Alchlaihawi(Concord Repatriation General Hospital), Peter Hendy(Mater Health Services), Daniel R. van Langenberg(Eastern Health), Richard B. Gearry(Waitaki Biosciences (New Zealand)), Jane M. Andrews(Health Net), Lena Thin(The University of Western Australia), Kirstin M. Taylor(Guy's Hospital), Robert Gilmore(The University of Queensland), Leonie Ruddick-Collins(The University of Queensland), Susan J. Connor(Liverpool Hospital), Julien D. Schulberg(The University of Melbourne), Charlotte Daker(North Shore Hospital), Satomi Okano(QIMR Berghofer Medical Research Institute), Simon Ghaly(UNSW Sydney), Matt Begun(UNSW Sydney), Yoon‐Kyo An(Mater Hospital), Olivia Sallis(Royal Adelaide Hospital), Krupa Krishnaprasad(QIMR Berghofer Medical Research Institute), Veronika Schreiber(Mater Research), Miles Sparrow(Alfred Health), Tianhong Wu(Royal Brisbane and Women's Hospital), Gabrielle Wark(St Vincent's Hospital Melbourne), Maxter Thai(Mater Health Services), Graham Radford‐Smith(QIMR Berghofer Medical Research Institute)
Cited by 1
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k